Description

Higginson et al identified factors predicting the need for palliative thoracic radiation therapy following first-line chemotherapy in a patient with a non-small cell lung cancer (NSCLC). These patients may require more aggressive management. The authors are from the University of North Carolina in Chapel Hill.


 

Patient selection: Stage IIIB or IV NSCLC following first-line chemotherapy

 

Development of lobar collapse secondary to bronchial obstruction is an indication for palliative thoracic radiation therapy.

 

Parameters associated with a need for palliative radiation therapy from the multivariate analysis:

(1) diameter of hilar disease in cm

(2) obstructive pneumonia at presentation (prior to chemotherapy)

Parameter

Finding

Points

diameter of hilar disease

<= 3 cm

0

 

> 3 cm

1

obstructive pneumonia

absent

0

 

present

1

 

number of risk factors =

= SUM(points for the 2 parameters)

 

Interpretation:

• minimum number of risk factors: 0

• maximum number of risk factors: 2

• The need for palliatrive radiation therapy increased with the number of risk factors.

• A patient with no hilar disease is least likely to require an intervention for a pulmonary event.

 

Number of Risk Factors

Risk for Palliative RT

Median Overall Survival

0

low to moderate

11.3 months

1

moderate

7.4 months

2

high

5 months

 

Additional risk factors from the univariate analysis:

(1) bronchial or vascular obstruction

(2) cough or chest pain

 


To read more or access our algorithms and calculators, please log in or register.